The Gratitude Gallery - A Positive Psychology Intervention
1 other identifier
interventional
13
1 country
1
Brief Summary
This study will assess the feasibility and acceptability of a positive psychology intervention, The Gratitude Gallery, for increasing gratitude in adults. The study hypothesizes that participants will find the activity feasible and acceptable and complete the intervention as directed. The project also hypothesizes that those that complete the intervention will show an increase in self-reported gratitude, as well as a decrease in symptoms of anxiety and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started Mar 2021
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2021
CompletedFirst Posted
Study publicly available on registry
January 25, 2021
CompletedStudy Start
First participant enrolled
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2021
CompletedDecember 17, 2021
December 1, 2021
8 months
January 20, 2021
December 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of the The Gratitude Gallery
Number of participants that are eligible for the study compared to the number of patients that are enrolled. The higher the ratio of participants enrolled the higher acceptability.
2 years
Feasibility of the The Gratitude Gallery
Participants that complete 15 of the 21 intervention days will be considered to be feasible.
up to 21 days (days of treatment)
Changes in the level of reported gratitude as measured by the Gratitude Questionnaire - 6 (GQ-6).
This is a six question, self-reported survey designed to assess individual differences in the proneness to experience gratitude in daily life. The GQ-6 uses a 7-point Likert scale with responses that range from "strongly disagree" to "strongly agree". Questions 3 and 6 are reverse scored. A higher total score indicated higher levels of gratitude.
Baseline, up to day 60
Secondary Outcomes (5)
Changes in positive and negative affect as measured by the Positive and Negative Affect Scale (PANAS) Scale
Baseline, up to day 60
Changes in General Life Satisfaction - Fixed Form B from the NIH Toolbox
Baseline, up to day 60
Changes in sleep quality using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance - Short Form 4a
Baseline, up to day 60
Changes in depressive symptoms using the Patient Health Questionnaire 9-Item (PHQ-9)
Baseline, up to day 60
Changes in anxiety symptoms using the Generalized Anxiety scale (GAD-7)
Baseline, up to day 60
Study Arms (1)
Taking Photographs
EXPERIMENTALParticipants will be asked to take photos with their cell phone.
Interventions
Participants will photograph images (using a cell phone) that invoke a feeling of gratitude. At least 1 photograph (at any time of the day) should be taken for a period of three weeks. Once the photo images are captured, the participant should spend a moment looking at the image and reflecting on why they are grateful for the subject of the photograph.
Eligibility Criteria
You may qualify if:
- Able to read/understand English and give consent
- Owns a smart phone capable of taking pictures
- Willing and able to comply with all aspects of study procedures
- PHQ-9 score greater or equal to 5 but less or equal to 14 with no suicidal ideation
- Generalized anxiety disorder (GAD-7) score greater or equal to 0 but less or equal to 9
- No plan to initiate a new program that could increase positive affect during the study period (e.g., psychotherapy, new exercise regimen, meditation classes)
- If on medication then stable (at least 3 months) on dose or not on medication
You may not qualify if:
- Having a psychotic disorder active suicidality or severe depressive or anxiety symptoms
- Other factors that at the discretion of the investigators that would adversely affect study participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erin Hendriks, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Family Medicine
Study Record Dates
First Submitted
January 20, 2021
First Posted
January 25, 2021
Study Start
March 16, 2021
Primary Completion
November 2, 2021
Study Completion
November 2, 2021
Last Updated
December 17, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share